Question 70

CellCept is used in REMS to prevent pregnancy.

CellCept, also known as mycophenolate mofetil, is indicated in the Risk Evaluation and Mitigation Strategy (REMS) program to prevent pregnancy due to its teratogenic effects. It is crucial for patients taking this medication to manage the risk of birth defects.

A) Creon

Creon is a pancreatic enzyme replacement therapy used for the treatment of pancreatic insufficiency. It is not associated with any REMS program related to pregnancy prevention, making it an incorrect choice in this context.

B) CellCept

CellCept is correctly identified as a medication under a REMS program that requires precautions to prevent pregnancy. Due to its potential to cause serious birth defects, patients are advised to use effective contraception while on this medication.

C) Celexa

Celexa, or citalopram, is an antidepressant that is not linked to a REMS program for pregnancy prevention. While it may have other side effects, it does not pose the same risks as CellCept regarding pregnancy, thus making it an incorrect option.

D) Cialis

Cialis is primarily used to treat erectile dysfunction and does not have a REMS program related to pregnancy prevention. There are no significant teratogenic risks associated with Cialis, rendering it an incorrect choice for this specific question.

Conclusion

CellCept is the only option among the choices that is part of a REMS program specifically aimed at preventing pregnancy due to its risks of teratogenic effects. The other options do not involve similar safety measures or risks, confirming that CellCept is the definitive correct answer in this context.